Оновлено 11 трав. 2023 р., 6:10 пп Опубліковано 15 лип. 2022 р., 5:11 пп Перекладено AI
Large pharmaceutical companies focus on fighting the most common (and therefore profitable) disorders. A new DAO wants to restructure incentives and boost research into rarer diseases. (Morsa/Getty Images)